Rifampicin at High Dose for Difficult-to-Treat Tuberculosis

NCT04768231 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
130
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Hospital Universitari Vall d'Hebron Research Institute

Collaborators